Facebook
Twitter
Telegram
Report an ErrorBioventus Balance Sheet 2011-2024 | BVS
Annual Balance Sheet Bioventus
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
334 M | 358 M | 244 M | 86.5 M | 133 M | 152 M | - | - | 184 M | 155 M | - | - | - |
Long Term Debt |
367 M | 385 M | 340 M | 173 M | 188 M | 190 M | - | - | 150 M | 162 M | - | - | - |
Long Term Debt Current |
4.06 M | 3.55 M | 3.5 M | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | 238 M | 232 M | - | - | 207 M | 201 M | - | - | - |
Total Current Liabilities |
175 M | 304 M | 181 M | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
590 M | 960 M | 618 M | 350 M | 327 M | 297 M | - | - | 295 M | 253 M | - | - | - |
Deferred Revenue |
2.35 M | 2.9 M | 2.4 M | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-322 M | -165 M | -6.6 M | -145 M | -142 M | -140 M | - | - | -91.8 M | -56.5 M | - | - | - |
Total Assets |
811 M | 1.37 B | 1.23 B | 494 M | 472 M | 443 M | - | - | 487 M | 430 M | - | - | - |
Cash and Cash Equivalents |
37 M | 30.2 M | 99.2 M | 86.8 M | - | - | - | - | - | - | - | - | - |
Book Value |
221 M | 412 M | 608 M | 144 M | 146 M | 145 M | - | - | 192 M | 177 M | - | - | - |
Total Shareholders Equity |
174 M | 325 M | 608 M | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Balance Sheet Bioventus
| 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
355 M | 375 M | 375 M | 404 M | 385 M | 393 M | 351 M | 348 M | 340 M | 162 M | 166 M | 170 M | 173 M | 173 M | 173 M | 173 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
577 M | 585 M | 604 M | 647 M | 960 M | 1.02 B | 689 M | 675 M | 692 M | 424 M | 427 M | 423 M | 350 M | 350 M | 350 M | 350 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | 2.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-326 M | -315 M | -308 M | -304 M | -165 M | -133 M | -25.1 M | -17.9 M | -6.6 M | -6.24 M | -5.17 M | -1.04 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
794 M | 811 M | 837 M | 887 M | 1.37 B | 1.4 B | 1.21 B | 1.2 B | 1.23 B | 655 M | 647 M | 643 M | 494 M | 494 M | 494 M | 494 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
25.2 M | 26.8 M | 29.4 M | 47.1 M | 30.2 M | 34.4 M | 41 M | 82.7 M | 43.9 M | 131 M | 138 M | 124 M | 86.8 M | 86.8 M | 86.8 M | 86.8 M | 64.5 M | - | - | - | 42.8 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
217 M | 226 M | 233 M | 240 M | 412 M | 379 M | 520 M | 522 M | 534 M | 230 M | 219 M | 220 M | 144 M | 144 M | 144 M | 144 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
171 M | 178 M | 183 M | 240 M | 325 M | 451 M | 592 M | 594 M | 459 M | 230 M | 219 M | 220 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency